[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352825-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352825-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mavs-as-a-key-regulator-of-tumor-proliferation-survival-the-tumor-microenvironment-and-immunity","MAVS as a Key Regulator of Tumor Proliferation, Survival, the Tumor Microenvironment, and Immunity","","The mitochondrial anti-viral signaling protein MAVS functions as a central regulator of innate anti-viral immunity. Prior work showed that MAVS is overexpressed in cancer and that its downregulation reduces cell proliferation while affecting transcriptional and inflammatory protein programs. Here, CRISPR/Cas9-mediated MAVS depletion in PC-3 prostate cancer cells suppresses proliferation, impairs immune evasion, and reshapes the tumor microenvironment. LC-MS/MS proteomics of MAVS-KO cells reveals broad pathway shifts spanning immunity, signaling, mitochondrial function, metabolism, protein synthesis/degradation, and epigenetic regulation, with enhanced apoptosis and reduced PD-L1 expression in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mavs-as-a-key-regulator-of-tumor-proliferation-survival-the-tumor-microenvironment-and-immunity/352825/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mavs-as-a-key-regulator-of-tumor-proliferation-survival-the-tumor-microenvironment-and-immunity/352825.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the role of MAVS in innate anti-viral immunity?","Question",{"text":63,"@type":64},"MAVS is a central regulator of innate anti-viral immunity, triggering signaling pathways that lead to type I interferon production and pro-inflammatory cytokines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MAVS depletion affect prostate cancer cells in this study?",{"text":68,"@type":64},"CRISPR/Cas9-mediated MAVS depletion in PC-3 cells suppresses proliferation, disrupts immune evasion, and alters the tumor microenvironment.",{"name":70,"@type":61,"acceptedAnswer":71},"What in vivo findings support MAVS as a potential anti-cancer target?",{"text":72,"@type":64},"MAVS-KO cells formed very small subcutaneous tumors in mice, with reduced proliferation, increased apoptosis, diminished cancer stem-cell populations, increased immune infiltration, and reduced PD-L1 expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352825,1790528075,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Article  \nMAVS as a Key Regulator of Tumor Proliferation, Survival, the Tumor Microenvironment, and Immunity  \nSweta Trishna 1, Anna Shteinfer-Kuzmine 2, Vered Chalifa-Caspi 3 and Varda Shoshan-Barmatz 1,2, *  \nAcademic Editor: Anna Rita Franco Migliaccio  \nReceived: 18 February 2026  \nRevised: 15 March 2026  \nAccepted: 20 March 2026  \nPublished: 26 March 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel; [shweta.trishna@gmail.com](shweta.trishna@gmail.com)  \n2 National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel; [shteinfe@post.bgu.ac.il](shteinfe@post.bgu.ac.il)  \n3 Ilse Katz Institute for Nanoscale Science and Technology, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel; [veredcc@bgu.ac.il](veredcc@bgu.ac.il)  \n* [Correspondence: vardasb@bgu.ac.il](Correspondence: vardasb@bgu.ac.il)  \nAbstract  \nThe mitochondrial anti-viral signaling protein, MAVS, is a central regulator of innate anti-viral immunity. Recently, we demonstrated that MAVS is overexpressed in cancer, where its downregulation resulted in reduced cell proliferation and the expression and nuclear translocation of proteins associated with transcriptional regulation and inflammation. In this study, we demonstrate that CRISPR/Cas9-mediated MAVS depletion in PC-3 prostate cancer cells suppresses proliferation, disrupts immune evasion, and alters the tumor microenvironment. Proteomic profiling of the MAVS-KO cells by LC-MS/MS revealed changes in the expression of proteins associated with immunity, cell signaling, mitochondrial function, metabolism, protein synthesis and degradation, and epigenetic regulation. In contrast to MAVS-expressing cells, MAVS-KO cells implanted subcutaneouslyin mice formed very small tumors. This inhibited tumor growth was linked to reduced proliferation, and enhanced apoptosis, as indicated by strong TUNEL staining and elevated activated caspase-3 . Importantly, the small “tumors” derived from MAVS-KO cells displayed a distinct morphology: diminished cancer stem-cell populations, an altered tumor microenvironment and inflammatory response, increased immune cell infiltration, and reduced PD-L1 expression. Together, these findings establish MAVS as a key mediator of cancer-cell survival, inflammation, and immune regulation, and, thus, its upregulation in tumors makes it a potential anti-cancer target.  \nKeywords: cancer; immunity; mitochondria; MAVS  \n1. Introduction  \nMitochondria, the powerhouse of the cell, are the signaling hub for regulating metabolism apoptosis, the cell cycle, proliferation, differentiation, epigenetics, immune signaling, and aging processes [1] . Mitochondria also serve as integrators and amplifiers of programed cell death [2] .  \nMitochondrial signaling is necessary for responses to activators of innate immune signaling, and mitochondrial signaling dictates macrophage polarization and function [3,4] . The importance of the mitochondria to cellular and organismal homeostasis is reflected by the association of mitochondrial dysfunction with a wide range of human pathologies, including neurodegenerative and metabolic diseases, aging, and cancer [5] .  \nOne of the links between the mitochondria and immune signaling is the mitochondrial anti-viral-signaling (MAVS) protein, also known as IFN-β promoter stimulator I (IPS-1), caspase activation recruitment domain adaptor inducing I FN-β (CARDIF), or the virusinduced signaling adaptor (VISA) [6,7] . MAVS, at the outer mitochondrial membrane (OMM), plays a central role in initiating the anti-viral innate immune response in mitochondria [8–11], triggered by viral RNA recognition through retinoic acid-inducible gene I (RIG-I) and other RIG-I-like receptors (RL","cbCaiiq02XDwbLU1","https://ap.wps.com/l/cbCaiiq02XDwbLU1","pdf",3331252,26,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What is the role of MAVS in innate anti-viral immunity?\",\"answer\":\"MAVS is a central regulator of innate anti-viral immunity, triggering signaling pathways that lead to type I interferon production and pro-inflammatory cytokines.\"},{\"question\":\"How does MAVS depletion affect prostate cancer cells in this study?\",\"answer\":\"CRISPR/Cas9-mediated MAVS depletion in PC-3 cells suppresses proliferation, disrupts immune evasion, and alters the tumor microenvironment.\"},{\"question\":\"What in vivo findings support MAVS as a potential anti-cancer target?\",\"answer\":\"MAVS-KO cells formed very small subcutaneous tumors in mice, with reduced proliferation, increased apoptosis, diminished cancer stem-cell populations, increased immune infiltration, and reduced PD-L1 expression.\"}]","MAVS as a Key Regulator of Tumor Proliferation, Survival, the Tumor Microenvironment, and Immunity | PDF",1790101540,66,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d88d97c0e60c0e9edad625080146fcd.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55858595c966f14b602087f53774ed06.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61445dcf76aa4c5feafc8b51b6ffa5b2.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2309c3154a788cca2b93b97dc9ca554e.webp",980,1385]